Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 07/30/15 → 04/30/17 |
Funding
- Biogen IDEC: $7,225.00
A Phase 4 Multicenter, Open-Label, Single Arm Study to Evaluate Switching From BRACED/Fingolimod to Natalizumab in Subjects with Relapsing Forms of Multiple Sclerosis (MS)
- Coyle, Patricia (PI)
- Melville, Patricia (CoPI)
Project: Research